Characterization of Fludarabine Phosphate Crystalline Forms
Crystal Growth & Design · 05.08.2026 · 26 (15) · 6136-6141
DOI: 10.1021/acs.cgd.6c00662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 17.07.2026. Verfasst von Michal Hušák und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantov? Agentura Cesk? Republiky, Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy.
Abstract (Originalsprache)
Fludarabine (9-β-d-arabinofuranosyl-2-fluoroadenine) is a purine analogue used for the treatment of various types of lymphoid malignancies. It is administered in its phosphate form; however, ts crystal structure has not been reported previously. In this work, we present the structural determination of two solid forms of fludarabine phosphate: Form I (hydrate) and Form II (anhydrate). The structures were elucidated using a combination of X-ray powder diffraction, DFT computations, solid-state NMR and TGA/DSC experiments. In addition, we discuss the preferred protonation state and the dehydration process of the investigated phases.
Förderung
- Grantov? Agentura Cesk? Republiky
- Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy
Zitieren
APA
Hušák, M., Jegorov, A., Rohlíček, J., Blahut, J., & Dračínský, M. (2026). Characterization of Fludarabine Phosphate Crystalline Forms. Crystal Growth & Design, 26(15), 6136-6141. https://doi.org/10.1021/acs.cgd.6c00662
Vancouver
Hušák M, Jegorov A, Rohlíček J, Blahut J, Dračínský M. Characterization of Fludarabine Phosphate Crystalline Forms. Crystal Growth & Design. 2026;26(15):6136-6141. doi:10.1021/acs.cgd.6c00662
BibTeX
@article{Husak2026,
author = {Hušák, Michal and Jegorov, Alexandr and Rohlíček, Jan and Blahut, Jan and Dračínský, Martin},
title = {Characterization of Fludarabine Phosphate Crystalline Forms},
journal = {Crystal Growth & Design},
year = {2026},
volume = {26},
number = {15},
pages = {6136--6141},
doi = {10.1021/acs.cgd.6c00662}
}
EUVIMED